Linezolid (as part of an optimized background regimen for MDR-TB)
Treatment used for 1 condition
Total Trials
50
Total Participants
10K
Avg Effectiveness
75%
Avg Safety Score
50%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.